macs monthly header with macs logo and graphic of medical professionals in training

The latest in substance use disorders and pain management education for healthcare providers

September 2025

Greetings,


Welcome to the September edition of the MACS Monthly Newsletter!


September is National Recovery Month, a time dedicated to increasing our understanding of substance use disorders, reducing stigma surrounding SUDs, and educating the public on effective prevention, treatment and recovery strategies. It is a month to celebrate the recovery community and highlight new, evidence-based approaches to care. According to the Substance Abuse and Mental Health Services Administration, 7 in 10 adults who have had a substance use problem consider themselves to be in recovery. Recovery is a tangible reality, leading to improvements in quality of life and well-being.


As part of National Recovery Month, we also observe National Addiction Professionals Day on September 20. This is an important day to acknowledge the vital role addiction professionals play in guiding individuals through their recovery journey. These dedicated professionals provide essential prevention, treatment, and recovery management services, working to create a healthier future for everyone affected by SUDs.


To continue enhancing your knowledge of SUDs during National Recovery Month and beyond, join us for a MACS webinar or ECHO session.


Providers can access support in caring for patients with SUDs and chronic pain by scheduling an individualized consultation or registering for an upcoming training with the MACS team of addiction medicine specialists. Call 1-855-337-MACS (6227) or visit www.marylandmacs.org to learn more.


Explore this newsletter and the tools available on the MACS website for additional information about provider education and treatment resources.


– The MACS Team

NEW: MDH RELEASES SUDORS TREND REPORT

The Maryland Department of Health released a State Unintentional Drug Overdose Reporting System (SUDORS) 2018-2024 Trend Report analyzing key circumstances surrounding unintentional fatal overdoses. View the summary with key messages, access the report or learn more about Maryland SUDORS, including state and county data on circumstances of opioid overdose deaths.

STIGMA IN HEALTHCARE SETTINGS

Check out your colleagues featured in our digital campaign with the Maryland Department of Health addressing stigma in healthcare settings.


Visit our informational webpage to learn more and hear directly from your colleagues in their own words.

EDUCATION

Upcoming MACS Training Opportunities

MACS Webinar

Presented in partnership with Maryland Behavioral Health Integration in Pediatric Primary Care (BHIPP)

Drinking and Alcohol Use Disorder in Youth


Thursday, September 25 | 12:00 p.m. – 1:00 p.m.


Presented by MACS Consultant Marc Fishman, MD

MACS Webinar

In observance of Pharmacy Week 2025


Tuesday, October 21 | 12:00 p.m. – 1:00 p.m.


Facilitated by MACS Consultant Bethany DiPaula, PharmD


Save the date! Registration link coming soon.

MACS Webinar

Confronting Stigma in Addiction Care


Thursday, December 4 | 12:00 p.m. – 1:00 p.m.


Presented by MACS Consultant Michael Fingerhood, MD


Save the date! Registration link coming soon.

Upcoming Trainings of Interest

National Council for Mental Wellbeing

PCSS-MOUD: Creating Optimal Access for OUD Services Utilizing Stages of Change


Thursday, September 4 | 3:00 p.m. – 4:00 p.m.

Maryland Reinforcing Overdose Prevention through Training and Advocacy

This is Not About Drugs


Friday, September 5 | 9:30 a.m. – 11:00 a.m.

Grayken Center for Addiction Training & Technical Assistance

Alcohol Use Disorders 101


Monday, September 15 | 1:00 p.m. – 2:00 p.m.

McLean Hospital

Healing Together: Tackling Addiction With Mental Health in Mind


Thursday, September 25 | 11:00 a.m. – 12:00 p.m.

MACS ECHO Sessions

Join our learning communities for continuous case-based discussions and didactic presentations linking expert specialist teams with healthcare providers and their practices. MACS ECHO sessions count toward the required 8-hours of SUD training for DEA license renewal or registration.

Opioid Treatment Program

Linkages to Care in OTP Settings – Cultivating Recovery


Gregory Malik Burnett, MD, MBA, MPH


Wednesday, September 3

12:30 p.m. – 1:30 p.m.

Maternal Health

Supporting Parents in Recovery With Young Children


Brijan M. Fellows, LCSW-C, PMH-C, IMH-E


Tuesday, September 9

12:00 p.m. – 1:00 p.m. New time!

CONFERENCES & EVENTS

American Case Management Association Maryland Chapter 2025 Annual Case Management and Transitions of Care Conference

Saturday, September 6

Bethesda North Marriott Hotel & Conference Center | Rockville, Maryland

MACS exhibit table

Association of Nigerian Nurse Practitioners in North America 2025 Educational Conference

Friday, September 12

DoubleTree by Hilton Hotel Columbia | Columbia, Maryland

MACS exhibit table

Maryland Academy of Physician Assistants 2025 Annual Conference

Thursday, September 25 – Saturday, September 27

Hyatt Regency Chesapeake Bay | Cambridge, Maryland

MACS exhibit table

NEWS

Alcohol Use Disorder Treatment Availability at Mental Health Treatment Facilities


This recently study published in JAMA Network Open, based on the 2023 National Substance Use and Mental Health Services Survey, highlights a significant gap in the treatment of alcohol use disorder (AUD) within mental health facilities. Of the 2,640 facilities that primarily provided mental health services, 73.6% provided SUD treatment, but only 9.9% offered medications for alcohol use disorder (MAUD). Facilities that accepted insurance and those that had a prescribing clinician were more likely to offer MAUD. This study reveals that while some facilities provide AUD services, a substantial portion do not, highlighting a missed opportunity within the mental health system.



Read more...

Oral methadone versus sublingual buprenorphine for the treatment of acute opioid withdrawal: A triple-blind, double-dummy, randomized control trial



In a study conducted at an inpatient drug treatment center in India, researchers compared oral methadone to sublingual buprenorphine for managing acute opioid withdrawal. Patients were randomly assigned to receive either medication, with doses titrated over days 1-3 to control withdrawal symptoms. Over days 4-10, the medications were tapered and stopped by day 11. Completion of treatment was similar in both groups (83% methadone, 82% buprenorphine). The study found that while both medications successfully reduced subjective (SOWS) and objective (COWS) withdrawal symptoms, the buprenorphine group experienced significantly greater withdrawal symptoms than the methadone group at the end of treatment on day 10 (p = 0.009). Opioid craving decreased in both groups, without significant differences. The authors concluded that methadone is a safe and effective alternative to buprenorphine for the management of opioid withdrawal.


Read more...

Implementation of a Statewide Fentanyl Possession Law and Opioid-Related Overdose Deaths


In an effort to combat the rise in opioid-related overdose deaths (OODs) from high-potency synthetic opioids like fentanyl, many states have classified fentanyl possession – even small amounts – as a felony. Colorado, for example, passed a 2022 law making possession of more than 1 gram of a substance containing any amount of fentanyl a felony punishable by up to 180 days in jail. Researchers conducted a cross-sectional study of adults in Colorado who experienced an OOD from January 2018 to November 2023 to evaluate the law's impact. The study found that while the overall OOD rate increased from 11.99 per 100,000 in 2018 to 25.0 per 100,000 in 2023, the total number of deaths did not significantly differ from the number predicted without the law. However, among the non-Hispanic Black population, OOD rates were significantly higher than predicted. The authors conclude that increasing criminal penalties for drug possession may not only fail to decrease OODs but could also worsen them.


Read more...

Feasibility and acceptability of a contingency management program for stimulant use disorder in a pallet shelter community for homeless-experienced veterans


Contingency management (CM) is the most effective psychosocial treatment for stimulant use disorder, but it is often underutilized. To test its feasibility and acceptability, a 12-week CM program based on the standard VA protocol was implemented at a pallet shelter community for homeless-experienced veterans in Los Angeles. The study used a mixed-methods approach, analyzing attendance and stimulant abstinence rates, and conducting interviews with both participants (n = 10) and staff (n = 6). The findings showed that the program had an average attendance rate of 32% and, based on urine drug screens, a stimulant abstinence rate of 49%. While participants found the program accessible and helpful for meeting immediate needs and engaging with health services, they also expressed concerns about privacy, stigma and the perceived insufficiency of the rewards. The authors suggest that these findings should be taken into consideration when developing CM programs for other community-based settings.


Read more...

Holidays

MACS Phone Line Will Be Closed

October 14 – Indigenous Peoples' Day

September Observances

National Recovery Month

Pain Awareness Month

Suicide Prevention Month

International Fetal Alcohol Spectrum Disorders Awareness Day

September 9

Telehealth Awareness Week

September 14 20

National Addiction Professionals Day

September 20

International Recovery Day

September 30

Follow us to stay connected:

Facebook  LinkedIn  X  Instagram  YouTube

RESOURCES

2024 National Survey on Drug Use and Health Annual National Report (SAMHSA)

Community Peer Project is ‘bridge’ between addiction and services in Baltimore (Baltimore Sun)

Drug Overdose Surveillance and Epidemiology 2023 Annual Report (MDH)

Maryland SUDORS 2018-2024 Trend Report (MDH)

The Effects of Stigma on Naloxone Attitudes and Policy Endorsement (Addiction Policy Forum)

X Share
LinkedIn Share

Follow us:

Facebook  X  LinkedIn  Instagram  YouTube